SLS

SELLAS Life Sciences Group, Inc.

3 catalysts on file

SLS

SELLAS Life Sciences Group, Inc.

Phase 3 AI-extracted

Acute Myeloid Leukemia (AML)

52d ago Jun 30, 2026

SEC 8-K verified 2mo ago

SLS

SELLAS Life Sciences Group, Inc.

Phase 2 AI-extracted

SLS009

Relapsed/Refractory (r/r) Acute Myeloid Leukemia (AML)

T-minus 40 days ~ Sep 30, 2026

SEC 8-K verified 2mo ago

SLS

SELLAS Life Sciences Group, Inc.

Phase 1 AI-extracted

SLS009

T-cell prolymphocytic leukemia (T-PLL)

Date TBD Date TBD

SEC 8-K verified 2mo ago